{"version":"1.0","provider_name":"The Catapult Network","provider_url":"https:\/\/catapult.org.uk","author_name":"india campbell","author_url":"https:\/\/catapult.org.uk\/author\/india-campbellcatapultnetwork-org-uk\/","title":"Launch of a drug discovery consortium to address the unmet therapeutic needs of people living with mental health conditions - The Catapult Network","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"Lvh6nShWZb\"><a href=\"https:\/\/catapult.org.uk\/our-work\/case-studies\/launch-of-a-drug-discovery-consortium-to-address-the-unmet-therapeutic-needs-of-people-living-with-mental-health-conditions\/\">Launch of a drug discovery consortium to address the unmet therapeutic needs of people living with mental health conditions<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/catapult.org.uk\/our-work\/case-studies\/launch-of-a-drug-discovery-consortium-to-address-the-unmet-therapeutic-needs-of-people-living-with-mental-health-conditions\/embed\/#?secret=Lvh6nShWZb\" width=\"600\" height=\"338\" title=\"&#8220;Launch of a drug discovery consortium to address the unmet therapeutic needs of people living with mental health conditions&#8221; &#8212; The Catapult Network\" data-secret=\"Lvh6nShWZb\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/catapult.org.uk\/wp-content\/uploads\/2021\/12\/MDC-DrugDiscovery-image-still-2.jpg","thumbnail_width":1920,"thumbnail_height":1080,"description":"The Psychiatry Consortium is a \u00a34 million international collaboration between seven global pharmaceutical companies and two leading medical research charities, convened and managed by Medicines Discovery Catapult, to support high-value drug discovery projects that address the unmet therapeutic needs of people living with mental health conditions, including psychiatric symptoms associated with dementia."}